NVS - Stock Quote for Novartis ADR representing 1 Ord Shs

|CustomizeNVS quote (NYSE Exchange)

55.30 +0.55 +1.00%fyi
After Hours: 55.15 -0.15/-0.27% Vol. 1,000
Previous Close	54.75	Bid	54.50
Open	55.23	Bid Size	100
Day's High	55.36	Ask	NA
Day's Low	54.83	Ask Size	NA
Volume	2.13 Mil	52 Week High	54.96
Avg. Daily Vol. (13 wk.)	1.33 Mil	52 Week Low	33.34

NVS Intraday Chart

5d 1m 3m 1y 3y 5y 10y

Beta	0.59
Dividend & Yield	1.71 (3.13%)
Earnings/Share	3.34
Forward P/E	13.39
Market Cap.	125.60 Bil
P/E	15.53
Return on Equity	14.59
Total Shares Out.	2.27 Bil

Quotes delayed 20 min unless otherwise indicated

Last trade (extended hours) 4:12 PM ET Financial data in U.S. dollars

Your latest quotes: NVS, QUSVX, TBL, FSAIX, AWSHX, DUG

News about NVS

Market Report -- In Play (NVS) 11/17/2009 Briefing.com
Novartis Teams Up With the US for Vaccines 6 hours ago Minyanville
Dividends for 100 Years 11/18/2009 Motley Fool
Serbia buys 3 million Swiss swine flu vaccines 11/13/2009 Associated Press
View all NVS news

Press releases

Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca 11/16/2009 Business Wire
Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. 11/19/2009 GlobeNewswire
View all NVS news

News from the Web

'Fast Money' Recap: Gold Conundrum 57 minutes ago At TheStreet.com
$ 10 for the Money Yesterday At Barron's
Now Is the Time to Buy Risk 11/20/2009 At Motley Fool
Streetwalker: Five International Bets 11/17/2009 At Forbes
View all NVS news

Videos about NVS

Celling Flu Vaccines

Novartis is trying to get ahead of the game with the first-ever U.S. based plant to make cell-based flu vaccines, with Dr. Daniel Vasella, Novartis...

more...

From Our Sponsors

Stock ratings